GLG LLC’s Arcturus Therapeutics ARCT Stock Holding History

GLG LLC’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-34,320	Closed	-$3.71M	–	605
2014 Q3	$3.71M	Buy	+34,320	New	+$4.47M	0.1%	265

Other funds holding ARCT

KCM

Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

LCM

Leisure Capital Management Costa Mesa, California $320M AUM 39.11% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

GLG LLC's ARCT Position: Q4 2014 in Review

GLG LLC sold out of Arcturus Therapeutics (ARCT) in Q4 2014, closing a stake of 34,320 shares — an estimated $3.71M sold.

GLG LLC first reported a position in ARCT in Q3 2014 and held it in 1 quarter. The position peaked at $3.71M in Q3 2014. 28 funds tracked by Wall St. Rank hold ARCT as of Q4 2014.

GLG LLC reported no remaining Arcturus Therapeutics position as of Q4 2014 after selling out during the quarter.
GLG LLC sold 34,320 Arcturus Therapeutics shares in Q4 2014, an estimated $3.71M.
GLG LLC first reported a position in Arcturus Therapeutics in Q3 2014 and held it in 1 quarter.
GLG LLC's Arcturus Therapeutics position peaked at $3.71M in Q3 2014.
28 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2014.

Based on GLG LLC's 13F filing for Q4 2014, filed 17 Feb 2015.